Umecrine Cognition attends INBC 2024 to present new preclinical data showing conserved dopamine signaling in Parkinson’s disease
STOCKHOLM – October [17], 2024. Umecrine Cognition today announces that the company will attend the 10th Edition of the International Conference on Neurology and Brain Disorders (INBC 2024) to…